Marshall Wace’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-518,200
Closed -$43.5M 3276
2025
Q3
$43.5M Buy
518,200
+350,200
+208% +$28.8M 0.04% 363
2025
Q2
$13.3M Buy
+168,000
New +$13.4M 0.02% 733
2025
Q1
Sell
-140,000
Closed -$13.9M 2914
2024
Q4
$13.9M Buy
+140,000
New +$14.4M 0.02% 674
2021
Q4
Sell
-71,000
Closed -$5.33M 4146
2021
Q3
$5.33M Buy
+71,000
New +$5.4M 0.02% 901

Other funds holding MRK

Marshall Wace's MRK Position: Q1 2026 in Review

Marshall Wace reduced its Merck (MRK) stake by 30% in Q1 2026, selling an estimated $138M and leaving 2,778,301 shares worth $334M. The position accounts for 0.33% of the portfolio, ranked #35.

Marshall Wace first reported a position in MRK in Q2 2014 and has held it in 41 quarters since. The position peaked at $557M in Q1 2022. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Marshall Wace held 2,778,301 shares of Merck worth $334M as of Q1 2026.
  • Marshall Wace sold 1,191,168 Merck shares in Q1 2026, an estimated $138M.
  • Merck made up 0.33% of Marshall Wace's portfolio in Q1 2026, its #35 holding.
  • Marshall Wace first reported a position in Merck in Q2 2014 and has held it in 41 quarters since.
  • Marshall Wace's Merck position peaked at $557M in Q1 2022.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.